Amneal Pharmaceuticals, Inc.

AMRX ·Healthcare, Drug Manufacturers - General
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
DEFA14A Apr 22, 2026 DEFA14A
DEFA14A Apr 22, 2026 DEFA14A
8-K Apr 22, 2026 8-K
4/A Mar 27, 2026 FORM 4/A
4/A Mar 27, 2026 FORM 4/A
SCHEDULE 13D/A Mar 26, 2026
SCHEDULE 13G/A Mar 26, 2026
DEFA14A Mar 25, 2026 DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS
DEF 14A Mar 25, 2026 DEFINITIVE PROXY STATEMENT
4 Mar 5, 2026 FORM 4
4 Mar 5, 2026 FORM 4
4 Mar 5, 2026 FORM 4
4 Mar 5, 2026 FORM 4
4 Mar 5, 2026 FORM 4
4 Mar 5, 2026 FORM 4
4 Mar 3, 2026 FORM 4
4 Mar 3, 2026 FORM 4
4 Mar 3, 2026 FORM 4
4 Mar 3, 2026 FORM 4
4 Mar 3, 2026 FORM 4
4 Mar 3, 2026 FORM 4
10-K Feb 27, 2026 10-K
8-K Feb 27, 2026 8-K
8-K Feb 3, 2026 8-K
8-K Jan 28, 2026 8-K
← Newer Page 3 of 28 · 695 filings Older →